Eugène McFadden

1991–2025 年に発表

75
論文数
22,761
被引用数
65
h 指数
73
i10 指数

被引用数

Eugène McFadden の年別被引用数1991 年: 被引用 4 件1992 年: 被引用 1 件1993 年: 被引用 5 件1994 年: 被引用 6 件1995 年: 被引用 6 件1996 年: 被引用 18 件1997 年: 被引用 6 件1998 年: 被引用 13 件1999 年: 被引用 30 件2000 年: 被引用 53 件2001 年: 被引用 32 件2002 年: 被引用 31 件2003 年: 被引用 33 件2004 年: 被引用 56 件2005 年: 被引用 178 件2006 年: 被引用 304 件2007 年: 被引用 341 件2008 年: 被引用 209 件2009 年: 被引用 187 件2010 年: 被引用 161 件2011 年: 被引用 192 件2012 年: 被引用 140 件2013 年: 被引用 151 件2014 年: 被引用 94 件2015 年: 被引用 103 件2016 年: 被引用 76 件2017 年: 被引用 61 件2018 年: 被引用 56 件2019 年: 被引用 280 件2020 年: 被引用 348 件2021 年: 被引用 284 件2022 年: 被引用 271 件2023 年: 被引用 218 件2024 年: 被引用 346 件2025 年: 被引用 167 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,327 件、この内訳の 17.1%イタリア: 引用元論文 655 件、この内訳の 8.4%オランダ: 引用元論文 619 件、この内訳の 8%ドイツ: 引用元論文 567 件、この内訳の 7.3%イギリス: 引用元論文 534 件、この内訳の 6.9%スイス: 引用元論文 369 件、この内訳の 4.7%フランス: 引用元論文 359 件、この内訳の 4.6%日本: 引用元論文 344 件、この内訳の 4.4%中国: 引用元論文 295 件、この内訳の 3.8%韓国: 引用元論文 280 件、この内訳の 3.6%スペイン: 引用元論文 260 件、この内訳の 3.3%ベルギー: 引用元論文 251 件、この内訳の 3.2%
0%17.1%その他 24.7%

分野

  • Medicine93.4%
  • Biochemistry, Genetics and Molecular Biology2.7%
  • Materials Science1.3%
  • Engineering1.2%
  • Immunology and Microbiology0.2%
  • Computer Science0.2%
  • その他1%

トピック

  • Coronary Interventions and Diagnostics20.8%
  • Cardiac Imaging and Diagnostics11.7%
  • Acute Myocardial Infarction Research10.3%
  • Antiplatelet Therapy and Cardiovascular Diseases9.6%
  • Peripheral Artery Disease Management3.5%
  • Atrial Fibrillation Management and Outcomes3%
  • その他41.1%

共著者

全論文

検索で開く
  1. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    著者: , , , , , , , , , , , , , , , , , - Circulation 2018 被引用: 933

  2. Clinical End Points in Coronary Stent Trials

    著者: , , , , , , , , , , , , , , - Circulation 2007 被引用: 5,420

  3. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 被引用: 177

  4. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Anderson, Rick Andreae, Michaël Angioı̈, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Edouard Benit, Olivier F. Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Paweł Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrié, Ángel Cequier, Ply Chichareon, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Éric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Géza Fontos, José Francisco Díaz Fernández, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, G. Gałuszka, Vasco Gama Ribeiro, Scot Garg, Giuseppe Gargiulo, Tobias Geisler, Валери Гелев, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Felice Gragnano, Ana Guimarães, Christian W. Hamm, Michael Haude, Dik Heg, Pieter Heijke, Rosa Ana Hernández Antolín, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd H. Hofma, Lene Holmvang, Stephen P. Hoole, Iván Horváth, Kurt Huber ほか 103 名 - The Lancet 2018 被引用: 785

  5. Standardized End Point Definitions for Coronary Intervention Trials

    著者: , , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 311

  6. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - BMJ 2021 被引用: 255

  7. Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Cardiology 2024 被引用: 86

  8. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Valgimigli - Journal of the American College of Cardiology 2019 被引用: 148

  9. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2024 被引用: 95

  10. P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2023 被引用: 119

  11. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy

    著者: , , , , , , , , , , , , , - The Lancet 2004 被引用: 1,437

  12. Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Claude Morice, Stephan Windecker, Yoshinobu Onuma, Enrico Frigoli, Andrè Frenk, Peter C. Jüni, Jan G.P. Tijssen, Dragica Paunovic, Mullasari S. Ajit, Mirvat Alasnag, Jozef Bartúnek, Antonio Colombo, David Hildick‐Smith, Andrés Íñiguez, Felix Mahfoud, Ran Kornowski, Maciej Lesiak, Paul Jau Lueng Ong, Alfredo E. Rodríguez, Marco Roffi, Carl Schultz, Goran Stanković, Pim A.L. Tonino, Aris Moschovitis, Peep Laanmets, Michael Donahue, M Bertrand, Stuart Pocock, Philip Urban, Sergio Leonardi, Claude Hanet, Renato D. Lópes, Eugène McFadden, Peter W. Radke, Risto O. Roine, Boudijn Ladan, Laura van der Waal, Yvonne Engelbrecht, Fred Paddenburg, Ben Ren, Ingrid de Zwart, Liliane Elshout, Judith Jonk, Tessa Rademaker‐Havinga, Ria van Vliet, Phani Krishna Kondamudi, Laure Morsiani, U. Windhövel, Anita van der Wal, C.D. Bakker, Kazuhiro Minagawa, Juan Mieres, Fernando Cura, Carlos Fernández‐Pereira, A. Lee, Nigel Jepson, Robert Whitbourn, Owen Christopher Raffel, Kurt Huber, Franz Weidinger, Fazila-Tun-Nesa Malik Hasselt, Jessa Ziekenhuis, Imelda Ziekenhuis, Willem Dewilde, Adel Aminian, Emanuele Aalst, Suzanne Pourbaix, Panagiotis Xaplanteris, Vasil Velchev, Dimitar Karageorgiev ほか 109 名 - JAMA Cardiology 2023 被引用: 30

  13. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey W. Moses, David M. Greer, John K. Forrest, David R. Holmes, A. Pieter Kappetein, Michael J. Mack, Andreas Baumbach - European Heart Journal 2017 被引用: 158

  14. Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 被引用: 93

  15. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Jüni, Stephan Windecker, Marco Valgimigli - European Heart Journal - Cardiovascular Pharmacotherapy 2020 被引用: 63

  16. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samantha Sartori, Brian Kirkham, Javier Escaned, Dik Heg, Stephan Windecker, Stuart Pocock, Peter Jüni, Marco Valgimigli, Roxana Mehran, Stephan Windecker, Pascal Vranckx, Patrick W. Serruys, Gabriel P. Steg, Christian W. Hamm, Usman Baber, Dominick J. Angiolillo, David J. Cohen, George Dangas, Shamir R. Mehta, Michael C. Gibson, Adnan Kastrati, Mitchel Krucoff, Magnus Öhman, Paul A. Gurbel, Timothy D. Henry, David J. Moliterno, Samin K. Sharma, Stuart Pocock, Peter Jüni, Bruno R. da Costa, Brian Kirkham, Samantha Sartori, Dierik Heg, Eugène McFadden, Sergio Leonardi, Raffaele Piccolo, Anna Franzone, Steven O. Marx, Bruce Darrow, Nicola Corvaja, Douglas DeStefano, Newsha Ghodsi, Jose Meller, Theresa Franklin-Bond, Jin Young, Zaha Waseem, Peter Jüni, Bruno R. da Costa, Brian Kirkham, Kurt Huber, Giora Weisz, Ran Kornowski, Vijay Kunadian, Keith G. Oldroyd, Yaling Han, Upendra Kaul, Bernhard Witzenbichler, Vladimír Džavík, Robert Gil, Dariuz Dudek, Gennaro Sardella, Javier Escaned, Richard Shlofmitz, Carlo Briguori, Edouard Benit, Christoph Liebetrau, Luc Janssens, Maurizio Ferrario, Aleksander Żurakowski, Roberto Diletti ほか 16 名 - JACC: Cardiovascular Interventions 2021 被引用: 37

  17. Endothelial Progenitor Cell Capture by Stents Coated With Antibody Against CD34

    著者: , , , , , , , , , , , - Journal of the American College of Cardiology 2005 被引用: 545

  18. Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusions

    著者: , , , , , , , , - The American Journal of Cardiology 2005 被引用: 194

  19. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

    著者: , , , , , , , , , - European Heart Journal 2005 被引用: 386

  20. Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 被引用: 279

  21. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention

    著者: , , , , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2019 被引用: 66

  22. High-Resolution Spiral Computed Tomography Coronary Angiography in Patients Referred for Diagnostic Conventional Coronary Angiography

    著者: , , , , , , , , - Circulation 2005 被引用: 1,015

  23. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

    著者: , , , , , , - The Lancet 2010 被引用: 687

  24. Randomized Multicenter Comparison of Conventional Anticoagulation Versus Antiplatelet Therapy in Unplanned and Elective Coronary Stenting

    著者: , , , , , , , , , , , , , , , - Circulation 1998 被引用: 584